In conclusion, our combined predictive model, which integrated DECT parameters using volumetric spectral analysis, demonstrated satisfactory diagnostic performance in differentiating Ki-67 and TTF-1 expression in patients with NSCLC, thereby providing valuable information for personalized treatment. This evidence concerns the gene TTF1 and non-small cell lung carcinoma.